trending Market Intelligence /marketintelligence/en/news-insights/trending/oW-BDkM7oNA2kSQXdkbHCw2 content esgSubNav
In This List

Aradigm regains compliance with Nasdaq listing rule

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Aradigm regains compliance with Nasdaq listing rule

Aradigm Corp. regained compliance with the Nasdaq listing rule requiring the company to maintain a market value of listed securities of $35 million or greater for 10 consecutive business days.

The specialty pharmaceutical company received a noncompliance notice from Nasdaq on April 4, saying the company did not comply with the minimum requirement of $2.5 million stockholders' equity, or $35 million market value of listed securities, or $500,000 of net income from continuing operations.

Aradigm will continue to be listed on the Nasdaq Capital Market.